{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-092728","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.688829+00:00","generated_at":"2026-05-31T11:57:11.667245+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"STAAR Surgical Q2 net sales $99.0M (record), EPS $0.15, raises FY2024 guidance","bullets":["Record Q2 net sales of $99.0M (up 7% YoY); constant currency $100.4M (+9%).","Net income $7.4M ($0.15 diluted EPS) vs $6.1M ($0.12) YoY; Adjusted EBITDA $22.5M ($0.45).","Gross margin improved to 79.2% from 76.6% YoY, helped by cataract IOL reserve changes.","U.S. ICL sales $5.5M (+25% YoY, +10% sequentially); China ICL sales +3% YoY.","FY2024 net sales guidance raised to $340M-$345M (from $335M-$340M); Adjusted EBITDA ~$42M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-092728","json":"https://secwatch.observer/filing/0000950170-24-092728.json","markdown":"https://secwatch.observer/filing/0000950170-24-092728.md","text":"https://secwatch.observer/filing/0000950170-24-092728.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/0000950170-24-092728-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017024092728/staa-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:57:11.667245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}